Form 4 for DGX Quest Diagnostics
Accepted 2026-05-21 16:54:02 ET · period of report 2026-05-20 · accession 0001805909-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 16:54 | 2026-05-20 | DGX | Lassiter Wright III | Dir | A - Grant | $0.00 | +1,142 | 10.3K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-20 | A | A | 1,142 | $0.00 | 10,317 | D | — | — | (F1) Represents an award of restricted stock units. (F2) The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |